News | May 15, 2015

Accreditation for Cardiovascular Excellence Publishes New Standards for Electrophysiology and ICDs

Evidence-based guidelines offer comprehensive review of interventional procedures for heart rhythm disorders

Accreditation for Cardiovascular Excellence, standards, EP, ICDs, guidelines

May 15, 2015 — Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and implantable cardioverter defibrillator (ICD) standards for accreditation. Driven by the latest available clinical evidence, the EP and ICD standards are a comprehensive review of interventional procedures in patients and adults with heart rhythm disorders.

"The ACE Standards for Electrophysiology (EP) and Implantable Cardioverter Defibrillators (ICD) Accreditation will allow EP laboratories to evaluate themselves against other facilities performing similar procedures and have input from an unbiased body of experts to help promote quality improvement within their center," said Michael S. Katcher, M.D., FHRS, director of cardiac electrophysiology and pacing, North Shore Medical Center. "These standards meet the needs of the EP laboratory, because they include diagnostic and therapeutic procedures and the core functions of EP labs."

Prior to the development of the ACE standards, however, no broad based performance guidance had been published for quality care in the EP and ICD settings. The new ACE Standards define the current evidence-based best practices for a variety of diagnostic and interventional procedures and device implantation.

The ACE EP and ICD Standards will be launched at the ACE exhibit at the 2015 Heart Rhythm Society 2015 (HRS 2015) meeting, May 13-16, in Boston. 

For more information: www.cvexcel.org

Related Content

Feature | Implantable Cardioverter Defibrillator (ICD) | By Dave Fornell, Editor

February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific ...

Home February 02, 2021
Home
News | Implantable Cardioverter Defibrillator (ICD)

January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found ...

Home January 08, 2021
Home
News | Implantable Cardioverter Defibrillator (ICD)

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System ...

Home May 08, 2020
Home
Feature | Implantable Cardioverter Defibrillator (ICD)

May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable ...

Home May 08, 2020
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 11, 2019 — Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational ...

Home October 11, 2019
Home
News | Implantable Cardioverter Defibrillator (ICD)

September 18, 2019 — Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention ...

Home September 18, 2019
Home
Feature | Implantable Cardioverter Defibrillator (ICD) | Dave Fornell, Editor

This is a brief overview of updates on implantable cardioverter defibrillators (ICD), including new technology ...

Home May 24, 2019
Home
News | Implantable Cardioverter Defibrillator (ICD)

May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of the ...

Home May 13, 2019
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 9, 2018 — Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable ...

Home August 09, 2018
Home
Feature | Implantable Cardioverter Defibrillator (ICD)

July 11, 2018 — Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and ...

Home July 11, 2018
Home
Subscribe Now